Apollo Life Sciences (ASX: AOP) is a biotechnology company that has made major breakthroughs in the areas of drug delivery and expression of proteins from human cells. Apollo's combined technologies are expected to lead to more effective and lower cost therapeutics, compared to first generation protein-based drugs.
| Website | http://apollolifesciences.com |
| Revenue | $7 million |
| Employees | 1 (0 on RocketReach) |
| Address | Level 1 147 Queen St, Beaconsfield, New South Wales 2015, AU |
| Phone | +61 2 9310 1800 |
| Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Competitors | Roche, Thermo Fisher Scientific, BD, Agilent Technologies, FUJIFILM Diosynth Biotechnologies, Illumina, Sony, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +47 more (view full list) |
| SIC | SIC Code 581 Companies, SIC Code 58 Companies |
| NAICS | NAICS Code 7225 Companies, NAICS Code 72251 Companies, NAICS Code 72 Companies, NAICS Code 722 Companies, NAICS Code 722513 Companies |
Looking for a particular Apollo Life Sciences Ltd employee's phone or email?
Apollo Life Sciences Ltd Questions
The Apollo Life Sciences Ltd annual revenue was $7 million in 2026.
Apollo Life Sciences Ltd is based in Beaconsfield, New South Wales.
The NAICS codes for Apollo Life Sciences Ltd are [7225, 72251, 72, 722, 722513].
The SIC codes for Apollo Life Sciences Ltd are [581, 58].
